Aktien

InterCure sets 1-for-5 reverse stock split for Aug. 24, 2026
The move aims to lift the share price above Nasdaq’s $1 minimum bid requirement. Trading will continue under the same ticker INCR.

Zaptec posts record Q2 revenue as EV charging orders surge 94%
Norwegian EV charging firm Zaptec reported a 32% revenue increase to 506 million NOK in Q2 2026, while order intake nearly doubled to 894 million NOK. EBITDA rose 57% to 69 million NOK as margins expanded.

Zaptec posts record Q2 2026 revenue, shares rise 0.3%
Norwegian EV charging firm Zaptec reported 506 million NOK in revenue, up 32% YoY, while order intake surged 94%. Shares edged up 0.32% to $47.50 in early trading.

Burckhardt Compression plans up to 220 job cuts in restructuring drive
Swiss compressor maker to slash up to 150 roles in Winterthur and 70 internationally, targeting annual savings of 20 million francs by 2026.

Straumann posts 7.8% organic revenue growth in H1, confirms 2026 outlook
Zahnimplantatehersteller Straumann reports 2.3% total revenue growth to CHF 1.38 billion in H1, with organic sales up 7.8%. CEO transition announced as Daniellot steps down after seven years.

Emmi posts 2.2% revenue rise in H1 2026, lifts annual outlook
Swiss dairy group Emmi reports stronger-than-expected first-half growth, with revenue up 2.2% to CHF 2.32bn, while maintaining full-year EBIT and net margin guidance.

KME plans Frankfurt IPO for copper-nickel unit Cunova worth up to $1.2 bln
Italian metals group KME has selected Berenberg and UniCredit to lead an IPO for its copper-nickel unit Cunova in Frankfurt, with a potential valuation of €1 billion. Listing could occur in 2026 or 2027.

Geberit lifts H1 sales on volumes, price hikes; shares surge 7%
Swiss sanitary products maker posts 2.8% reported net sales growth in first half, driven by higher volumes and pricing, while maintaining full-year guidance. Shares jump over 7% on strong Q2 beat.

Taiho and Cullinan to present lung cancer drug trial results at 2026 conference
Phase 3 REZILIENT3 trial of Zipalertinib plus chemotherapy met its primary endpoint in EGFR exon 20 insertion mutation-positive NSCLC patients. Results to be showcased at IASLC World Conference.

US stocks mixed pre-market; Moderna surges 100% on cancer therapy data
Moderna jumps 100% in premarket trading after data showed its personalized mRNA cancer vaccine combined with Merck’s Keytruda cut melanoma recurrence. SMI rises 0.36% as Lowe’s cuts guidance, Estee Lauder gains.

WiseTech Global shares plunge 11.5% after ACCC raid
Logistics software firm faces regulatory scrutiny as Australian watchdog demands documents related to global supply chain services. Shares hit session lows within minutes.

Zaptec posts record Q2 revenue, order intake surges 94%
Norwegian EV charging firm reports 32% revenue growth and a 97% jump in order backlog. Europe’s top AC charging provider expands production as plug-in vehicle sales rise.

Desert Control sees 500% jump in pilot projects, lifts 2026 revenue target
The agritech firm raised its full-year revenue guidance to $2 million, citing a surge in Tier 1 pilots and a $56 million potential pipeline. Stock remains near 52-week lows.

Kuaishou Q2 profit steady as stock slides 4% on margin pressure
Revenue rose 1.4% year-over-year to 35.5 billion yuan, but gross margin narrowed to 51.6% as costs climbed. Kling AI revenue tripled to over 850 million yuan.

Moderna, Merck melanoma vaccine trial succeeds in late-stage study
Interim results show mRNA-based therapy cuts recurrence risk in high-risk patients. Moderna shares jump 60% in premarket trading.

Swiss SMI slips on rising yields; Geberit earnings loom, oil climbs
Swiss benchmark down 0.13% as global bond yields hit multi-decade highs; Geberit to report half-year results. Oil rises on Hormuz Strait risks as tech stocks retreat.

SK Hynix union nears wage deal amid profit-sharing dispute
South Korean chipmaker’s labor union finalizes preliminary terms for a 10-year operating profit distribution agreement, including a 10% cash payout to workers. Approval from union members remains pending.

Value-Investing: So finden Anleger unterbewertete Aktien
Systematische Suche nach günstigen Titeln erfordert fundamentale Analyse und Geduld. Experten raten zu branchenübergreifenden Kennzahlenvergleichen und qualitativen Faktoren.

Guernsey court places Ceiba Investments into administration management
Royal Court of Guernsey appoints joint administrators after regulator flags undue risk. Company’s shares suspended on London’s Specialist Fund Segment.

SHAPE posts AUD 1.2 bln revenue in FY 2026, up 30% on year
Australian construction group SHAPE reported record annual revenue of AUD 1.2 billion for FY 2026, a 30% increase from the prior year. EBITDA rose 53% to AUD 50.1 million, while net profit climbed 50% to AUD 31.7 million.
South Korea’s KOSPI halts trade after 5% slide amid chip stock rout
KOSPI index briefly suspended trading after falling more than 5% as SK Hynix and Samsung led declines in semiconductor shares. U.S. chip index also dropped sharply.

Mirvac lifts FY2026 profit 7%, announces A$200m buyback
Australian property group Mirvac reported a 7% rise in operating profit to A$508m, while shares gained 6.6% after it guided FY2027 earnings growth and launched a A$200m on-market buyback.

Temple & Webster posts record FY26 revenue but warns of weak FY27 start
Australia’s largest online furniture retailer reported 11% revenue growth for FY26 but flagged a 13% year-to-date sales decline in FY27. Shares fell 16.6% to $4.21 amid cautious outlook.

Energy One lifts FY2026 revenue, eyes GMSL acquisition to expand European footprint
Recurring revenue grew 17% YoY to AUD 64.6m as Energy One targets a 30% cash EBITDA run-rate by FY2027. GMSL deal, slated to close by November 2026, is expected to double its European customer base and boost EPS by 35%.

